Fig. 1From: Cumulative smoking dose affects the clinical outcomes of EGFR-mutated lung adenocarcinoma patients treated with EGFR-TKIs: a retrospective studyComparisons of PFS and OS according to cumulative smoking dose in patients receiving EGFR-TKIs. Comparison of PFS by (a) smoking history, and (b) cumulative smoking dose. Comparison of OS by (c) smoking history and (d) cumulative smoking doseBack to article page